11 Feb 2025
⚖️Executive Order 14200
Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Summary
Executive Order 14200 addresses amendments to duties concerning the synthetic opioid supply chain from China. It revises specific subsections regarding duty-free treatment for eligible articles, contingent on the establishment of adequate systems for tariff revenue collection. The order underscores compliance obligations without creating enforceable rights against the U.S. government.
Agencies
- Executive Office of the President
Business Impact
$$ - Med
The Executive Order modifies tariff treatments related to the synthetic opioid supply chain, impacting businesses engaged in importing covered articles. The amendment for "de minimis" duty-free treatment can influence pricing, compliance costs, and operational strategies once systems for tariff revenue collection are established.